Last reviewed · How we verify
NCT05953779
Personalized Need-focused Single Session Intervention
NA trial testing Clinician-administered Need-focused Single Session Intervention in Depression and/or Anxiety in the Mild-to-moderate Range in 240 participants. Status unknown.
31 July 2024
Quick facts
| Lead sponsor | Bar-Ilan University, Israel |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 240 |
| Start date | 8 January 2023 |
| Primary completion | 31 July 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 2 locations across United States, Israel |
Drugs / interventions tested
- Clinician-administered Need-focused Single Session Intervention
Conditions studied
- Depression and/or Anxiety in the Mild-to-moderate Range — all drugs for Depression and/or Anxiety in the Mild-to-moderate Range →
Sponsor
Bar-Ilan University, Israel
Who can join
18 and older, any sex, with Depression and/or Anxiety in the Mild-to-moderate Range. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a two-site randomized controlled trial, with two goals. First, the investigators aim to demonstrate that single-session interventions for mild-to-moderate anxiety and depression can generate statistically significant symptom change as a main effect across control and experimental (i.e. personalized) conditions. Second, the investigators hope to establish the additional incremental efficacy of personalization via person-specific intensive longitudinal data collection and analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05953779
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Bar-Ilan University, Israel trials
Trials by the same sponsor.
- NCT05640882 — Is Olfaction the Key to PTSD · NA · unknown
- NCT05301257 — SOSteniamoci: An Internet-based Intervention to Support Informal Caregivers. · NA · completed
- NCT05341440 — Deciphering the Salutogenic Effects of Close Relationships: Psycho-physiological Coregulation Processes and Their Outcom · unknown
- NCT05902832 — Computer-Mediated Intervention to Enhance Emotional Competence in Children With Autism in Schools · NA · unknown
- NCT05045859 — A Couples' Intervention Protocol for PTSD · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05953779 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bar-Ilan University, Israel
- Last refreshed: 20 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05953779.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing